What Follow-Up Is Needed After Breast Cancer Treatment? Is Ultrasound Alone Enough?

Completing breast cancer treatment can bring both great relief and new uncertainty for many women. Patients who were monitored closely during treatment may feel lost when follow-up appointments become less frequent afterward. Follow-up care is therefore very important. This article examines in detail what to expect after breast cancer treatment, what follow-up visits involve, and why this process matters.

What Is the Follow-Up Plan After Treatment?

After completing breast cancer treatment, it is common to worry about cancer recurrence . Some patients with advanced breast cancer may face situations in which treatment never fully ends. They may continue treatment to control the cancer and relieve symptoms, bringing a different kind of stress and uncertainty.

After treatment, your doctors will continue to monitor you closely. During these visits, your doctor examines you and asks about any problems you are experiencing. Laboratory or imaging tests may sometimes be performed.

Which Tests Are Performed During Follow-Up?

Your follow-up care plan may vary depending on many factors, including the type and stage of breast cancer and how it was treated:

• Doctor Visits: After treatment, follow-up visits are generally every 3 months for the first 2 years. As more time passes, they become less frequent and are usually annual after 5 years.

• Breast Imaging (Mammography and Ultrasound): If you have had breast-conserving surgery (lumpectomy or partial mastectomy), you may need mammography approximately 6 to 12 months after surgery and radiotherapy, and annually thereafter. Breast ultrasound may also be recommended alongside mammography, particularly in women with dense breast tissue, where it can help detect abnormalities. Women who have had a mastectomy (removal of the entire breast) generally do not need mammography on that side, but annual mammography and ultrasound when needed may be required for the other breast.

• Breast magnetic resonance imaging (MRI) is recommended for women at high risk. Particularly for those with genetic mutations such as BRCA1 or BRCA2, a history of breast cancer, or dense breast tissue, MRI can provide a more detailed assessment alongside mammography and ultrasound. MRI may help detect cancer at an early stage and can therefore be used in follow-up after treatment in some women.

• Gynecological Examinations: If you take hormonal medicines such as tamoxifen and have a uterus, your oncologist may recommend an annual pelvic or gynecological examination. These medicines can cause thickening of the uterine lining . An annual gynecological examination after breast cancer treatment is therefore important.

• Bone Density Tests: If you take an aromatase inhibitor, such as anastrozole, letrozole, or exemestane, for early-stage breast cancer, or if treatment has caused menopause, your doctor may wish to monitor your bone health closely and measure your bone density. The test used for this is called DEXA.

• Blood Tests: Many cancer centers recommend regular blood tests after treatment. These include monitoring overall health and checking vitamin and mineral levels, correcting them when necessary. Tumor markers, such as CA-15-3, CA-125, or CEA, may also be measured. Their levels may help determine whether cancer has returned or progressed. However, these markers do not rise in every patient and are not used routinely in patients without symptoms.

• Other Tests: Bone scans, computed tomography (CT), or PET-CT scans are not part of standard follow-up for most women treated for breast cancer. However, they may be performed if symptoms, complaints, or physical examination findings suggest recurrence.

• Minimal Residual Disease Tests: Some people who have completed treatment are now also being followed using minimal residual disease (MRD = minimal residual disease) tests. These aim to assess the likelihood of recurrence by measuring cancer DNA fragments in the blood. However, planning for these tests should begin at diagnosis. Although they have not yet received approval from the FDA (United States Food and Drug Administration) or a similar regulatory health authority, they are regarded as a promising method for cancer monitoring. Their use after breast cancer treatment is a promising approach to detecting early signs of recurrence.

If Cancer Returns

If recurrence is detected, your treatment options will depend on where the cancer has returned, your previous treatments, and your current health. A PET-CT scan may also be recommended when recurrence is suspected.

Create a Follow-Up Plan

Discuss developing a survivorship care plan with your doctor. This may include:

• A summary of your diagnosis, tests, and treatment

• A recommended schedule of follow-up examinations and tests

• A schedule of screening tests for other cancers or tests to investigate long-term health effects of treatment

• A list of potential late or long-term adverse effects of your treatment and when to watch for them

• Recommendations on diet, physical activity, and other lifestyle changes